EP4 agonists have reduced bronchodilatation activity in patients with Group III Pulmonary Hypertension

dc.contributor.author	ÖZEN, Gülsev
dc.contributor.author	NOREL, XAVIER
dc.contributor.author	BENYAHIA, CHABHA
dc.contributor.author	H, Mal
dc.contributor.author	SILVERSTEIN, ADAM
dc.contributor.author	Bayles, Richard
dc.contributor.author	AC, Nelsen
dc.contributor.author	Castier, Y
dc.contributor.author	Clapp, Lucie
dc.contributor.author	LONGROIS, DAN
dc.date.accessioned	2021-03-04T12:20:41Z
dc.date.available	2021-03-04T12:20:41Z
dc.identifier.citation	NOREL X., BENYAHIA C., ÖZEN G., H M., SILVERSTEIN A., Bayles R., AC N., Castier Y., Clapp L., LONGROIS D., "EP4 agonists have reduced bronchodilatation activity in patients with Group III Pulmonary Hypertension", WCP2018, Kyoto, Japonya, 1 - 06 Temmuz 2018, ss.154
dc.identifier.other	vv_1032021
dc.identifier.other	av_76d02229-3e9b-4909-a0a8-1bae8ea0447b
dc.identifier.uri	http://hdl.handle.net/20.500.12627/81579
dc.language.iso	eng
dc.subject	Eczacılık
dc.subject	Yaşam Bilimleri (LIFE)
dc.subject	Farmakoloji ve Toksikoloji
dc.subject	Sağlık Bilimleri
dc.subject	Meslek Bilimleri
dc.title	EP4 agonists have reduced bronchodilatation activity in patients with Group III Pulmonary Hypertension
dc.type	Bildiri
dc.contributor.department	Fransa , ,
dc.contributor.firstauthorID	354510

Files in this item

Files	Size	Format	View
There are no files associated with this item.